Revive Therapeutics Ltd (RVVTF)

[Jack Torrance]

I don't disagree with any of that. I only said RVVT's OPTIMAL window was in late fall, IMO. They can still get approval and still do well with Buc, but the delay in their phase 3 trial has really hurt their potential. I don't think anyone can deny that. The landscape has changed drastically. A LOT has happened with vaccines and other treatments since December. If they could have gotten EUA on Buc by late November, the share price would have rocketed clear past Neptune. An approval now won't be as explosive, IMO.